CAY10568 – 100 mg

Brand:
Cayman
CAS:
22913-17-3
Storage:
-20
UN-No:
Non-Hazardous - /

Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. Selective analgesia through TRPV1-mediated entry of a cationic lidocaine derivative, QX314, was recently reported.{15625} CAY10568 is a physically smaller, less hydrophobic version of QX314 designed to be even more permeable to TRPV1 ion channel when activated by agonists such as capsaicin and N-oleoyl dopamine. CAY10568 when given in combination with suitable TRPV1 agonists should produce selective blockade of the pain response while leaving motor, touch, and proprioception intact.  

 

Available on backorder

SKU: 10012565 - 100 mg Category:

Description

A physically smaller, less hydrophobic version of the lidocaine derivative QX314 designed to be more permeable to the TRPV1 ion channel for selective analgesia through TRPV1


Formal name: trimethyl[(phenylcarbamoyl)methyl]-ammonium iodide

Synonyms:  Santinamide

Molecular weight: 320.2

CAS: 22913-17-3

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals||Research Area|Neuroscience|Pain Research